ACM
Ascendant Capital Management Portfolio holdings
AUM
$75.2M
1-Year Est. Return
12.68%
This Fund
S&P 500
1 Year Est. Return
+12.68%
AUM
$75.2M
AUM Growth
+$42.4M
(+129%)
Holding
82
Top Buys
| 1 | +$6.14M | |
| 2 | +$3.54M | |
| 3 | +$3.53M | |
| 4 |
Invesco Taxable Municipal Bond ETF
BAB
|
+$3.19M |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$2.62M |
Top Sells
| 1 | +$2.45M | |
| 2 | +$1.64M | |
| 3 | +$1.35M | |
| 4 |
Eli Lilly
LLY
|
+$1.1M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.04M |
Sector Composition
| 1 | Technology | 12.49% |
| 2 | Consumer Discretionary | 12.12% |
| 3 | Financials | 3.75% |
| 4 | Communication Services | 3.39% |
| 5 | Materials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Regeneron Pharmaceuticals
REGN
$83.3B
| – | – |
-500
|
|
||
77
State Street SPDR S&P 500 ETF Trust
SPY
$694B
| – | – |
0
|
|
||
78
UnitedHealth
UNH
$264B
| – | – |
-1,500
|
|
||
79
United Therapeutics
UTHR
$21.1B
| – | – |
-2,000
|
|
||
80
Archer Daniels Midland
ADM
$32.3B
| – | – |
-8,500
|
|
||
81
AGNC Investment
AGNC
$12.2B
| – | – |
-35,000
|
|
||
82
Cardinal Health
CAH
$52.5B
| – | – |
-5,500
|
|